Compare NVAX & HSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVAX | HSAI |
|---|---|---|
| Founded | 1987 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.4B |
| IPO Year | 1996 | 2021 |
| Metric | NVAX | HSAI |
|---|---|---|
| Price | $12.78 | $16.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 19 |
| Target Price | $14.00 | ★ $28.49 |
| AVG Volume (30 Days) | ★ 6.6M | 885.1K |
| Earning Date | 11-05-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 309.76 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,123,479,000.00 | N/A |
| Revenue This Year | N/A | $41.85 |
| Revenue Next Year | N/A | $41.74 |
| P/E Ratio | ★ N/A | $61.18 |
| Revenue Growth | ★ 64.69 | N/A |
| 52 Week Low | $6.20 | $14.29 |
| 52 Week High | $13.39 | $29.35 |
| Indicator | NVAX | HSAI |
|---|---|---|
| Relative Strength Index (RSI) | 68.95 | 46.02 |
| Support Level | $7.64 | $15.81 |
| Resistance Level | N/A | $19.29 |
| Average True Range (ATR) | 0.97 | 0.40 |
| MACD | 0.11 | 0.01 |
| Stochastic Oscillator | 85.02 | 34.31 |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with enhanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.